Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR670 host gene (MIR670HG) is a long non-coding RNA gene that serves as the genomic origin for microRNA-670 (miR-670). While MIR670HG itself does not encode a protein, its product, miR-670, has been shown to regulate target genes such as Igf2bp1 and to play a regulatory role in processes like RNA modification and development of certain tumor types, including pituitary adenoma. There is no evidence it acts as a receptor, enzyme, or other classical therapeutic target class, and there are currently no drugs targeting MIR670HG directly. In summary, MIR670 host gene (MIR670HG) is a long non-coding RNA, not a therapeutic target, but its encoded miRNA may play important regulatory roles in gene expression and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR670 host gene (non-protein coding) (MIR670HG).